» Articles » PMID: 27415419

The Esophageal Microbiota in Health and Disease

Overview
Specialty Science
Date 2016 Jul 15
PMID 27415419
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

The esophageal mucosa is among the sites colonized by human microbiota, the complex microbial ecosystem that colonizes various body surfaces and is increasingly recognized to play roles in several physiological and pathological processes. Our understanding of the composition of the esophageal microbiota in health and disease is challenged by the need for invasive sampling procedures and by the dynamic nature of the esophageal environment and remains limited in comparison with the information available for other body sites. Members of the genus Streptococcus appear to be the major components of the microbiota of the healthy esophagus, although the presence of several other taxa has also been reported. Dysbiosis, consisting of enrichment in some Gram-negative taxa (including Veillonella, Prevotella, Haemophilus, Neisseria, Campylobacter, and Fusobacterium), has been reported in association with gastroesophageal reflux disease and is hypothesized to contribute to the evolution of this condition toward Barrett's esophagus (which is the most common esophageal precancerous lesion) and, eventually, adenocarcinoma. Some Campylobacter species (mostly C. concisus) are also putatively involved in the progression of disease toward adenocarcinoma. However, variable findings have recently been reported in additional studies. Causative relationships between dysbiosis or specific bacterial species and esophageal diseases remain controversial and warrant further investigations.

Citing Articles

Histopathological study of the localization/distribution of Fusobacterium nucleatum in esophageal cancer.

Sasaki-Higashimoto I, Fujishima F, Ishida H, Taniyama Y, Ozawa Y, Nakamura T Pathol Int. 2025; 75(2):82-91.

PMID: 39760468 PMC: 11848974. DOI: 10.1111/pin.13505.


From microbes to medicine: harnessing the power of the microbiome in esophageal cancer.

Liu X, Li B, Liang L, Han J, Mai S, Liu L Front Immunol. 2024; 15:1450927.

PMID: 39600698 PMC: 11588724. DOI: 10.3389/fimmu.2024.1450927.


Consideration of Antifungal Coverage in Treating Infections Related to Delayed Esophageal Perforation from Anterior Cervical Spine Hardware.

Prasad K, Ceremsak J, Gallant J, Kay H, Gettler E, Campbell B Infect Dis Rep. 2024; 16(6):1030-1035.

PMID: 39449386 PMC: 11503398. DOI: 10.3390/idr16060082.


Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.

Hara Y, Baba Y, Oda E, Harada K, Yamashita K, Toihata T Br J Cancer. 2024; 131(5):797-807.

PMID: 38992099 PMC: 11368944. DOI: 10.1038/s41416-024-02753-0.


Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer.

Li N, Gao L, Ge Y, Zhao L, Wang Y, Bai C Heliyon. 2024; 10(12):e32770.

PMID: 38984313 PMC: 11231538. DOI: 10.1016/j.heliyon.2024.e32770.